Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Innovative Cancer Drug Research Centre is a biotechnology organization focused on the discovery and development of novel therapeutic agents for various forms of cancer. The center specializes in identifying high-potential drug candidates through advanced screening and molecular modeling techniques, with a particular emphasis on targeted therapies. Their research portfolio includes small molecules and biologics designed to inhibit key pathways in tumor growth and metastasis. By collaborating with academic and clinical partners, the center aims to bridge the gap between basic oncological research and clinical application. Their current efforts are primarily in the pre-clinical stage, focusing on optimizing lead compounds for safety and efficacy.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Innovative Cancer Drug Research Centre.